Notice Title

Consent to the Distribution of New Medicines

Publication Date
18 Sep 2025

Tags

Medicines Act Consent to the distribution of new medicines Health

Notice Number

2025-go5147
Title
View PDF
File Type and Size
PDF (25 KB)

Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicines which were referred to the Minister of Health under the provisions of section 24(5) of the Act and are set out in the Schedule hereto:

Schedule

Product: Benzatropine Injection
Active Ingredient: Benzatropine mesilate 1mg/mL
Dosage Form: Solution for injection
New Zealand Sponsor: Phebra NZ Limited
Manufacturer: Phebra Pty Limited, Sydney, Australia
 
Product: Colgout
Active Ingredient: Colchicine 0.5mg
Dosage Form: Tablet
New Zealand Sponsor: Pharmacy Retailing (NZ) Limited t/a Healthcare Logistics
Manufacturers: Aspen Pharma Pty Limited, Melbourne, Australia
Strides Pharma Science Limited, Bangalore, India
 
Product: Dizole 50
Active Ingredient: Fluconazole 50mg
Dosage Form: Capsule
New Zealand Sponsor: Arrotex Pharmaceuticals (NZ) Limited
Manufacturer: Mylan Laboratories Limited, Nashik, India
 
Product: Flucazole
Active Ingredient: Fluconazole 150mg
Dosage Form: Capsule
New Zealand Sponsor: Arrotex Pharmaceuticals (NZ) Limited
Manufacturer: Mylan Laboratories Limited, Nashik, India
 
Product: Fluconazole
Active Ingredient: Fluconazole 50mg
Dosage Form: Capsule
New Zealand Sponsor: Arrotex Pharmaceuticals (NZ) Limited
Manufacturer: Mylan Laboratories Limited, Nashik, India
 
Product: Fluconazole
Active Ingredient: Fluconazole 150mg
Dosage Form: Capsule
New Zealand Sponsor: Arrotex Pharmaceuticals (NZ) Limited
Manufacturer: Mylan Laboratories Limited, Nashik, India
 
Product: Fluconazole
Active Ingredient: Fluconazole 200mg
Dosage Form: Capsule
New Zealand Sponsor: Arrotex Pharmaceuticals (NZ) Limited
Manufacturer: Mylan Laboratories Limited, Nashik, India
 
Product: Opdivo (40mg/4mL)
Active Ingredient: Nivolumab 10mg/mL
Dosage Form: Concentrate for infusion
New Zealand Sponsor: Bristol-Myers Squibb (NZ) Limited
Manufacturers: Vetter Pharma-Fertigung GmbH & Co KG, Ravensburg, Germany
Bristol-Myers Squibb Holdings Pharma Limited, Manati, Puerto Rico
 
Product: Opdivo (100mg/10mL)
Active Ingredient: Nivolumab 10mg/mL
Dosage Form: Concentrate for infusion
New Zealand Sponsor: Bristol-Myers Squibb (NZ) Limited
Manufacturers: Vetter Pharma-Fertigung GmbH & Co KG, Ravensburg, Germany
Bristol-Myers Squibb Holdings Pharma Limited, Manati, Puerto Rico


Dated this 12th day of September 2025.

MATTHEW SPENCER, Acting Group Manager, Medsafe, Ministry of Health (pursuant to delegation given by the Minister of Health on 11 September 2013).